Author
University of Science and Technology of ChinaORCID 0009-0003-0143-365XUnclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Shuo Chen, Shulin Wei, Tian Tian…·Suowen Xu
This paper shows tirzepatide reduces atherosclerosis independently of weight loss by directly targeting vascular inflammation through the cAMP/PKA/eNOS pathway.
Fan-shun Zhang, Chenyang He, Yanjun Yin…·Suowen Xu
Neratinib reduces atherosclerosis by inhibiting ASK1-mediated endothelial inflammation, showing potential as a repurposed drug for vascular disease.
Suowen Xu, Zhenghong Liu, Tian Tian…·Jianping Weng
This study shows halofuginone, an FDA-approved drug, reduces obesity in mice by increasing FGF21 and GDF15 levels, improving metabolic health.